Correlation Between Mirati Ther and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mirati Ther and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mirati Ther and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mirati Ther and Stoke Therapeutics, you can compare the effects of market volatilities on Mirati Ther and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mirati Ther with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mirati Ther and Stoke Therapeutics.
Diversification Opportunities for Mirati Ther and Stoke Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Mirati and Stoke is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mirati Ther and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Mirati Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mirati Ther are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Mirati Ther i.e., Mirati Ther and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Mirati Ther and Stoke Therapeutics
If you would invest 1,371 in Stoke Therapeutics on September 12, 2024 and sell it today you would lose (45.00) from holding Stoke Therapeutics or give up 3.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 1.59% |
| Values | Daily Returns |
Mirati Ther vs. Stoke Therapeutics
Performance |
| Timeline |
| Mirati Ther |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Stoke Therapeutics |
Mirati Ther and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mirati Ther and Stoke Therapeutics
The main advantage of trading using opposite Mirati Ther and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mirati Ther position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |